Keeping in mind that PTTG1 can mediate glioma cell proliferation, the signaling cascade ECT2/PMSD14/E2F1/PPT11G could be potentially targeted as a therapeutic approach [44,45]. The gene discussed is ECT2; the disease is central nervous system cancer.